NCT04489589View on ClinicalTrials.gov

Midodrine for the Early Liberation of Vasopressor Support in the ICU

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

October 30, 2022

Conditions
Critical IllnessShock
Interventions
DRUG

Midodrine

10mg PO/NG q8h

DRUG

Placebo

10mg PO/NG q8h

Trial Locations (1)

T5R0T1

University of Alberta Hospital, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

collaborator

Institute of Health Economics, Canada

OTHER

lead

University of Alberta

OTHER

NCT04489589 - Midodrine for the Early Liberation of Vasopressor Support in the ICU | Biotech Hunter | Biotech Hunter